Guidant Corp. ( GDT.N: Quote, Profile, Research) has found quality problems in some of its new stents and said on Wednesday it will delay the European launch of the heart device and stop enrolling patients in a clinical trial.
http://c.moreover.com/click/here.pl?r497429069
http://c.moreover.com/click/here.pl?r497429069